Esperion Therapeutics Inc...

NASDAQ: ESPR · Real-Time Price · USD
2.07
0.13 (6.70%)
At close: Aug 14, 2025, 3:59 PM
2.13
2.90%
Pre-market: Aug 15, 2025, 04:40 AM EDT
6.70%
Bid 2.01
Market Cap 410.27M
Revenue (ttm) 268.13M
Net Income (ttm) -96.09M
EPS (ttm) -0.5
PE Ratio (ttm) -4.14
Forward PE -187
Analyst Buy
Ask 2.15
Volume 6,415,589
Avg. Volume (20D) 4,674,248
Open 1.94
Previous Close 1.94
Day's Range 1.86 - 2.10
52-Week Range 0.69 - 3.94
Beta 0.82

About ESPR

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ESPR
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ESPR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Esperion Therapeutics has released their quartely earnings on Aug 5, 2025:
  • Revenue of $82.39M exceeds estimates by $18.04M, with 11.58% YoY growth.
  • EPS of -0.02 exceeds estimates by 0.14, with 93.94% YoY growth.
  • Next Earnings Release

    Esperion Therapeutics Inc. is scheduled to release its earnings on Nov 6, 2025, before market opens.
    Analysts project revenue of ... Unlock content with Pro Subscription
    1 week ago
    +8.72%
    Esperion Therapeutics shares are trading higher af... Unlock content with Pro Subscription
    5 months ago
    +12.03%
    Esperion Therapeutics shares are trading higher after the company reported better than expected Q4 FY24 earnings.